Our SoFi Technologies (NASDAQ:SOFI | SOFI Price Prediction) thesis is straightforward: the fintech is executing too well for the stock’s recent slide to last, even if the next 12 months bring more volatility than…
Our 24/7 Wall St. price target for Procter & Gamble (NYSE:PG | PG Price Prediction) is $163.50, implying a 14.95% upside from today’s price. Procter & Gamble trades at $142.24 as of May 13,…
NVIDIA (NASDAQ: NVDA | NVDA Price Prediction) closed its fiscal year on Feb. 25, 2026 with $68.13 billion in Q4 revenue, up 73.2% YoY. Alphabet (NASDAQ: GOOG) followed in late April with $109.90 billion…
Microsoft (NASDAQ:MSFT | MSFT Price Prediction) and Palantir (NASDAQ:PLTR) both delivered AI-fueled earnings beats this season, yet the businesses behind those tickers operate at completely different altitudes. Microsoft is the hyperscaler renting out the…
The memory rally has been one of the most extraordinary moves of the cycle, and SanDisk (NASDAQ:SNDK | SNDK Price Prediction) sits at the center of it. After a 3,197% gain over the past…
Few legacy tech names have staged a comeback like Cisco Systems (NASDAQ:CSCO | CSCO Price Prediction). After spending more than two decades in the wilderness post dotcom, the networking giant is suddenly an AI…
Our 24/7 Wall St. price target for Oracle (NYSE:ORCL | ORCL Price Prediction) is $245.34 over the next 12 months, implying 25.42% upside from $195.61. The recommendation is buy, with a 90% confidence level…
Broadcom (NASDAQ:AVGO | AVGO Price Prediction) and Microsoft (NASDAQ:MSFT) both delivered AI-fueled quarters revealing two different playbooks. Broadcom sells custom silicon and switches for hyperscaler data centers. Microsoft sells cloud, copilots, and the productivity…
Palantir Technologies (NASDAQ:PLTR | PLTR Price Prediction) has been one of the most polarizing names in the AI trade, and that tension is showing up clearly in the price action. After a euphoric run,…
Synopsys (NASDAQ:SNPS | SNPS Price Prediction) has staged one of the more dramatic comebacks in semiconductor software, climbing 21.78% in the past month after a brutal stretch through late 2025. With the Ansys integration…
POET Technologies (NASDAQ:POET) has gone from obscure micro-cap to one of the loudest tickers on WallStreetBets in a matter of weeks. The stock surged 114.72% in the past week alone after announcing a $500…
Dell Technologies (NYSE:DELL | DELL Price Prediction) has become one of the defining AI infrastructure trades of 2026, and our proprietary model sees room to run. Shares trade at $238.94 as of May 12,…
Qualcomm (NASDAQ:QCOM | QCOM Price Prediction) has staged one of the most dramatic semiconductor rebounds of 2026, ripping 50.62% off its March trough in roughly a month. Yet Reddit sentiment remains negative, and Wall…
Our Verizon (NYSE:VZ | VZ Price Prediction) call is straightforward: the stock is undervalued, the dividend is well covered, and the model points to meaningful upside over the next 12 months. With shares trading…
I’ll cut straight to the call. Super Micro Computer (NASDAQ:SMCI | SMCI Price Prediction) has been one of the most punished AI infrastructure names of the past year, but our proprietary model sees the…
NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) at $225.83 is a Buy, with shares pressing against a 52-week high of $227.84 as the AI infrastructure cycle delivers another record quarter. The question is whether a…
Memory has gone from commodity to strategic asset, and Micron Technology (NASDAQ:MU | MU Price Prediction) has been the biggest beneficiary on the public markets. Shares have rocketed 828.56% over the past year, and…
AMD (NASDAQ:AMD | AMD Price Prediction) and Intel (NASDAQ:INTC) both reported Q1 fiscal 2026 results within two weeks of each other, and the contrast is striking. AMD posted $10.25 billion in revenue powered by…
Tesla (NASDAQ:TSLA | TSLA Price Prediction) at $445.27 is a hold. The stock has run 26.35% in the past month on a clean Q1 margin reset, but it now trades above the Street’s consensus…
Eli Lilly (NYSE:LLY | LLY Price Prediction) just delivered one of the most impressive quarters in big pharma history, and the stock is responding. After a sharp drawdown in early 2026, shares have rebounded…
